FD&C
FDA Holds Public Meeting Exploring Scope of Dietary Supplement Ingredients
On March 27, the U.S. Food and Drug Administration (FDA) hosted a public meeting on the scope of dietary supplement ingredients. The event was held in-person from 9 a.m. to 3 p.m. EST at Wiley Auditorium, 5001 Campus Dr. in College Park, MD and virtually. FDA’s Office of Dietary Supplement Programs (ODSP) invited stakeholders to participate in ...
FDA Issues Letter on DSHEA Disclaimer Amendment, Industry Responds
On Dec. 11, the U.S. Food and Drug Administration (FDA) published a letter to the dietary supplement industry regarding the agency’s labeling regulations that govern the placement of the disclaimer on dietary supplements labels under the Federal Food, Drug and Cosmetic Act (FD&C) and Dietary Supplement Health and Education Act of 1994 (DSHEA). The agency ...
FDA Declares NMN Lawful in Dietary Supplements, Industry Reacts
The U.S. Food and Drug Administration (FDA) has reversed course and confirmed that Beta (β) Nicotinamide Mononucleotide (NMN) is lawful for use in dietary supplements. Responding to citizen petitions filed by the Natural Products Association (NPA), Council for Responsible Nutrition (CRN), and the Alliance for Natural Health (ANH), the FDA revised its interpretation of a ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
